Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

AmericaBy CountryBy RegionFor organizationsGrantOpportunities

Medtech Small Business Grant

The Blueprint Medtech Small Business Translator Grant

Summary:
This government grant, awarded by the National Institutes of Health (NIH), specifically supports small businesses developing innovative medical devices for treating nervous system disorders. It funds activities crucial for translating promising ideas into market-ready solutions, including prototype development, safety testing, and limited clinical studies to secure FDA approval.

Sponsor:

National Institutes of Health (NIH)

Eligibility:

  • U.S.-based small businesses defined as per the Small Business Administration (SBA) guidelines.
  • Businesses actively developing therapeutic or diagnostic medical devices targeting nervous system disorders.
  • Applicants can possess their own device concepts or be collaborating with established manufacturers.

Benefits:

  • Non-dilutive funding: Up to $100,000 in direct costs for Phase I, with potential for larger Phase II awards.
  • Cooperative research program: Collaborate with NIH program staff for project planning, monitoring, and guidance.
  • Expert assistance: Access specialists in regulatory affairs, intellectual property, commercialization, and strategic partnerships.
  • Contract research resources: Utilize specialized services for large animal testing, sterilization, biocompatibility assessment, manufacturing, and medical monitoring (if needed).

Deadline:

The next application deadline is February 20, 2024.

Apply Now

Related Articles

Check Also
Close
Back to top button
What do you like about this page?

0 / 400